Last updated on September 2018

Evaluation of SPN-812 ER High Dose in Children With ADHD

Brief description of study

This study will evaluate the efficacy and safety of high doses of SPN 812 ER in children with ADHD

Detailed Study Description

This is a multicenter, randomized, double-blind, placebo-controlled, 3-arm, parallel-group study, to assess the efficacy and safety of SPN-812 ER as monotherapy for the treatment of children 6-11 years old with ADHD.

Clinical Study Identifier: NCT03247543

Contact Investigators or Research Sites near you

Start Over

Fatima Chowdhry, MD

Alliance for Wellness
Long Beach, CA United States
  Connect »